antibody
| 2 min read
The updated brand identity underscores nearly 30 years of scientific leadership and a growing portfolio designed for modern preclinical discovery.
| 2 min read
Bio-Rad has expanded its portfolio of recombinant monoclonal anti-idiotypic antibodies and SpyCatcher reagents, enhancing support for bioanalytical assay development and antibody drug research.
| 1 min read
ProBioGen announced the commercial launch of Ziihera®, a bispecific antibody for HER2-positive biliary tract cancer developed with its GlymaxX® technology.
| 4 min read
The protein APLP1 strongly associates with brain-derived EVs. A blood test could one day isolate these molecular packets to diagnose neurological disorders.
Available on Demand
Scientists discover an ultra-rare monoclonal antibody directly from patients with autoimmune diseases.
| 4 min read
A new technique boosts the sensitivity of mass cytometry to allow detection and characterization of low-abundance markers, yielding new disease insights.
| 4 min read
Researchers precisely engineered an antibody to better treat respiratory depression due to overdose from increasingly prevalent synthetic opioids.
Available on Demand
Researchers embrace automation to speed up antibody purification for accelerated therapeutic breakthroughs.
| 8 min read
By activating CAR T cells only in the presence of an antibody switch, Travis Young and his team hope to make this cancer treatment safer and more effective.
| 3 min read
Researchers defined the structure of key Nipah virus proteins to develop vaccines and treatments for this deadly virus.
Page 1 of 1 - 10 Total Items
